Your browser doesn't support javascript.
loading
Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes.
Tang, Y-T; Wang, D; Luo, H; Xiao, M; Zhou, H-S; Liu, D; Ling, S-P; Wang, N; Hu, X-L; Luo, Y; Mao, X; Ao, Q-L; Huang, J; Zhang, W; Sheng, L-S; Zhu, L-J; Shang, Z; Gao, L-L; Zhang, P-L; Zhou, M; Zhou, K-G; Qiu, L-G; Liu, Q-F; Zhang, H-Y; Li, J-Y; Jin, J; Fu, L; Zhao, W-L; Chen, J-P; Du, X; Huang, G; Wang, Q-F; Zhou, J-F; Huang, L.
Afiliação
  • Tang YT; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang D; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Luo H; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xiao M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhou HS; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liu D; Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
  • Ling SP; Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
  • Wang N; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Hu XL; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Luo Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Mao X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Ao QL; Department of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Huang J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang W; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Sheng LS; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhu LJ; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Shang Z; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Gao LL; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang PL; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhou M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhou KG; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Qiu LG; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjing, China.
  • Liu QF; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang HY; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Li JY; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University and Jiangsu Province Hospital, Nanjing, China.
  • Jin J; Department of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China.
  • Fu L; Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Zhao WL; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chen JP; Department of Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Du X; Department of Hematology, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Huang G; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Wang QF; Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Zhou JF; Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
  • Huang L; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjing, China.
Blood Cancer J ; 7(12): 660, 2017 12 21.
Article em En | MEDLINE | ID: mdl-29263371

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Granular Grande Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Blood Cancer J Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Granular Grande Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Blood Cancer J Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China
...